暂无分享,去创建一个
[1] Max Welling,et al. Auto-Encoding Variational Bayes , 2013, ICLR.
[2] Yao Zhang,et al. Controlling Propagation at Group Scale on Networks , 2015, 2015 IEEE International Conference on Data Mining.
[3] Michalis K. Titsias,et al. Bayesian Time Series Models: Markov chain Monte Carlo algorithms for Gaussian processes , 2011 .
[4] Yao Zhang,et al. DAVA: Distributing Vaccines over Networks under Prior Information , 2014, SDM.
[5] Eduardo F. Morales,et al. An Introduction to Reinforcement Learning , 2011 .
[6] T. Stadler,et al. Practical considerations for measuring the effective reproductive number, Rt , 2020, medRxiv.
[7] Shahin Jabbari,et al. Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City , 2020, Proceedings of the National Academy of Sciences.
[8] K. Mandl,et al. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility , 2020, The Lancet Global Health.
[9] Michael I. Jordan,et al. Variational Bayesian Inference with Stochastic Search , 2012, ICML.
[10] Arash Vahdat,et al. DVAE++: Discrete Variational Autoencoders with Overlapping Transformations , 2018, ICML.
[11] Joseph Dureau,et al. Capturing the time-varying drivers of an epidemic using stochastic dynamical systems. , 2012, Biostatistics.
[12] C. Althaus,et al. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[13] Madhav V. Marathe,et al. Forecasting a Moving Target: Ensemble Models for ILI Case Count Predictions , 2014, SDM.
[14] Sam Abbott,et al. Practical considerations for measuring the effective reproductive number, Rt , 2020, PLoS computational biology.
[15] Naren Ramakrishnan,et al. SourceSeer: Forecasting Rare Disease Outbreaks Using Multiple Data Sources , 2015, SDM.
[16] George Turabelidze,et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. , 2020, JAMA internal medicine.
[17] C. Fraser,et al. A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics , 2013, American journal of epidemiology.
[18] Thibaut Jombart,et al. Bayesian inference of transmission chains using timing of symptoms, pathogen genomes and contact data , 2019, PLoS Comput. Biol..
[19] M. Pascual,et al. Inapparent infections and cholera dynamics , 2008, Nature.
[20] Ben Poole,et al. Categorical Reparameterization with Gumbel-Softmax , 2016, ICLR.
[21] Dustin Tran,et al. Automatic Differentiation Variational Inference , 2016, J. Mach. Learn. Res..
[22] Sam Abbott,et al. Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts , 2020, Wellcome Open Research.
[23] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[24] R N Thompson,et al. Improved inference of time-varying reproduction numbers during infectious disease outbreaks , 2019, Epidemics.
[25] S. Bhatt,et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.
[26] Sudip Saha,et al. Approximation Algorithms for Reducing the Spectral Radius to Control Epidemic Spread , 2015, SDM.
[27] Joseph Dureau,et al. Accounting for non-stationarity in epidemiology by embedding time-varying parameters in stochastic models , 2018, PLoS Comput. Biol..
[28] Madhav V. Marathe,et al. An interaction-based approach to computational epidemiology , 2008, AAAI 2008.
[29] Milind Tambe,et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance , 2020, medRxiv : the preprint server for health sciences.
[30] J. Wallinga,et al. Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.
[31] Galit Alter,et al. Dynamics and significance of the antibody response to SARS-CoV-2 infection , 2020, medRxiv.